Quick Nav
Pharmacy Times
News Briefs


Published Online: Wednesday, August 1, 2007   [ Request Print ]

The FDA will form a new advisory committee of outside specialists to advise the agency on how to inform the public about the risks and benefits of medicines and medical devices. The Risk Communication Advisory Committee will:

  • Help the FDA better understand the communication needs and priorities of the general public
  • Advise the FDA on the development of strategic plans to communicate product risks and benefits
  • Make recommendations to the FDA based on current research about crafting risk and benefit messages, as well as how to effectively communicate specific product information to vulnerable audiences

The committee "will bring together a broad range of experts and views to help improve the FDA's communication of the science-based information about product risks and benefits that the public needs to make informed decisions."

Related Articles
No Result Found

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.

Become a Member
Forgot Password?